IC3R grew out of an inaugural meeting in Lyon, France, in February 2019. This first IC3R meeting gathered representatives of major institutions involved in tumour classification and related fields to identify and discuss translational challenges in data comparability, standard-setting, quality management, evidence evaluation, and copyright, as well as to develop a collaborative plan for addressing these challenges. 32 people from 10 countries attended the meeting, many from organizations that have been working in this field in different regions of the world. The International Agency for Research on Cancer (IARC) and these sibling institutions perceived the need for an organization that would produce evidence reviews, evaluations, standards, and best practice recommendations for the field.
Support for this idea from pathologists, cancer researchers, and policy-makers led to the creation of the IC3R consortium in 2020, with the kick-off meeting held online due to the COVID-19 pandemic.
For more information on IC3R: